Skip to main content
. 2019 Apr 3;2019:2316237. doi: 10.1155/2019/2316237

Table 2.

Clinical relevance of miR-485 and miR-181c on GSE 22220 dataset.

has-miR-485-5p has-miR-181c
High (%) Low p value† High (%) Low p value†
Age
 <50 41 (58.6) 29 26 (37.1) 44
 ≧50 63 (45.0) 77 0.0632 79 (56.4) 61 0.0081
Grade
 1 27 (64.3) 15 26 (61.9) 16
 2 41 (50.0) 41 47 (57.3) 35
 3 40 (35.5) 73 0.0137 22 (35.5) 40 0.0092
Tumor size
 <2cm 38 (58.5) 27 36 (55.4) 29
 >=2cm 66 (45.5) 79 0.0823 69 (47.6) 76 0.2957
Lymph node
 0 59 (49.2) 61 65 (54.2) 55
 1-2 21 (47.7) 23 18 (40.9) 26
 >=3 24 (52.2) 22 0.9084 22 (47.8) 24 0.3036
ER status
 Negative 35 (42.7) 47 33 (40.2) 49
 Positive 69 (53.9) 59 0.1120 72 (56.3) 56 0.0233

Note: there are 1, 1, 1, 5, and 1 missing cases in age, tumor size, lymph node, grade, and ER status.

% represents positive rate of has-miR-485-5p/has-miR-181c is equal to N High/(N High+NLow)×100%.

p values were based on the Pearson Chi-square test.